- February 7, 2021
- Category: Drugs and Therapeutics, Healthcare and LifeSciences
Global Antipsychotic Drugs Market Size study, Antipsychotic Drugs Market by Drug Class (First Generation, Second Generation, Third Generation and Others), by Application (Schizophrenia, Dementia, Bipolar and Unipolar Depression) and Regional Forecasts 2021-2027
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion) 1.2.1. Antipsychotic Drugs Market, by Drug Class, 2019-2027 (USD Billion) 1.2.2. Antipsychotic Drugs Market, by Application, 2019-2027 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Antipsychotic Drugs Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Antipsychotic Drugs Market Dynamics 3.1. Antipsychotic Drugs Market Impact Analysis (2019-2027) 3.1.1. Market Drivers 126.96.36.199. Increased cases of psychotic disorders 188.8.131.52. Increased awareness for mental health and well-being 3.1.2. Market Challenges 184.108.40.206. Stigma attached to mental health disorders 3.1.3. Market Opportunities 220.127.116.11. Governmental support to raise awareness for treatment Chapter 4. Global Antipsychotic Drugs Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Antipsychotic Drugs Market, by Drug Class 5.1. Market Snapshot 5.2. Global Antipsychotic Drugs Market by Drug Class, Performance - Potential Analysis 5.3. Global Antipsychotic Drugs Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion) 5.4. Antipsychotic Drugs Market, Sub Segment Analysis 5.4.1. First Generation/Standard/Typical Antipsychotics Drug 5.4.2. Second Generation/Atypical Antipsychotics Drug 5.4.3. Third generation Antipsychotics Drug 5.4.4. Other market Chapter 6. Global Antipsychotic Drugs Market, by Application 6.1. Market Snapshot 6.2. Global Antipsychotic Drugs Market by Application, Performance - Potential Analysis 6.3. Global Antipsychotic Drugs Market Estimates & Forecasts by Application 2018-2027 (USD Billion) 6.4. Antipsychotic Drugs Market, Sub Segment Analysis 6.4.1. Schizophrenia 6.4.2. Bipolar Disorder 6.4.3. Depression 6.4.4. Dementia 6.4.5. Other psychotic disorders Chapter 7. Global Antipsychotic Drugs Market, Regional Analysis 7.1. Antipsychotic Drugs Market, Regional Market Snapshot 7.2. North America Antipsychotic Drugs Market 7.2.1. U.S. Antipsychotic Drugs Market 18.104.22.168. Drug Class breakdown estimates & forecasts, 2018-2027 22.214.171.124. Application breakdown estimates & forecasts, 2018-2027 7.2.2. Canada Antipsychotic Drugs Market 7.3. Europe Antipsychotic Drugs Market Snapshot 7.3.1. U.K. Antipsychotic Drugs Market 7.3.2. Germany Antipsychotic Drugs Market 7.3.3. France Antipsychotic Drugs Market 7.3.4. Spain Antipsychotic Drugs Market 7.3.5. Italy Antipsychotic Drugs Market 7.3.6. Rest of Europe Antipsychotic Drugs Market 7.4. Asia-Pacific Antipsychotic Drugs Market Snapshot 7.4.1. China Antipsychotic Drugs Market 7.4.2. India Antipsychotic Drugs Market 7.4.3. Japan Antipsychotic Drugs Market 7.4.4. Australia Antipsychotic Drugs Market 7.4.5. South Korea Antipsychotic Drugs Market 7.4.6. Rest of Asia Pacific Antipsychotic Drugs Market 7.5. Latin America Antipsychotic Drugs Market Snapshot 7.5.1. Brazil Antipsychotic Drugs Market 7.5.2. Mexico Antipsychotic Drugs Market 7.6. Rest of The World Antipsychotic Drugs Market Chapter 8. Competitive Intelligence 8.1. Top Market Strategies 8.2. Company Profiles 8.2.1. Johnson & Johnson 126.96.36.199. Key Information 188.8.131.52. Overview 184.108.40.206. Financial (Subject to Data Availability) 220.127.116.11. Product Summary 18.104.22.168. Recent Developments 8.2.2. Pfizer, Inc. 8.2.3. Eli Lilly & Co. 8.2.4. Bristol-Myers Squibb Company 8.2.5. AstraZeneca 8.2.6. Glaxo SmithKline, Plc 8.2.7. Allergan 8.2.8. Otsuka Pharmaceutical Co., Ltd. 8.2.9. Sumitomo Dainippon Pharma Co., Ltd. 8.2.10. Vanda Pharmaceuticals Inc. Chapter 9. Research Process 9.1. Research Process 9.1.1. Data Mining 9.1.2. Analysis 9.1.3. Market Estimation 9.1.4. Validation 9.1.5. Publishing 9.2. Research Attributes 9.3. Research Assumption
Global Antipsychotic Drugs Market is valued approximately USD 12.67 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 1.95% over the forecast period 2021-2027. A “psychotic disorder” is an umbrella term to describe multiple types of mental health conditions that involve a phenomenon called psychosis. The word ‘psychosis’ is used to describe conditions that affect the mind, where there has been some loss of contact with reality. It can be caused by some medications, alcohol or drug abuse. Schizophrenia, a common type, has patients often experiencing delusions or hallucinations. Antipsychotic drugs, also called tranquilizers, are prescribed to treat schizophrenia and to reduce the symptoms of bipolar and other disorders. With the growing cases of psychotic disorders such as bipolar, delusions etc. as well as continuous innovations in research of antipsychotic drugs are driving the growth of Antipsychotic Drugs market. According to World Health Organization, Schizophrenia affects 20 million people globally and usually starts earlier among men. In 2019, almost 69% of people with schizophrenia are not receiving suitable care. In 2019, 90% of people with untreated schizophrenia live in low- and middle- income countries. Also, lack of access to mental health services is an important issue. Stigma, discrimination and violation of human rights of people with psychotic disorders is common and people doesn’t incline to seek help. This may act as a restraint for its growth. However, increasing efforts from government to raise awareness for the treatment and acceptance of psychotic disorder patients may act as an opportunity for Antipsychotic Drugs Market in subsequent decade.
Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Antipsychotic Drugs Market. Due to greater awareness for mental health issues and disorders as well as higher per capita income, North America has emerged as the significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 increasing cases of bipolar and schizophrenic disorders and thus increased demand for antipsychotic drugs. Rising disposable income and growing awareness for mental health issues treatment will also boost growth in this region.
Major market player included in this report are:
Johnson & Johnson
Eli Lilly & Co.
Bristol-Myers Squibb Company
Glaxo SmithKline, Plc
Otsuka Pharmaceutical Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.
Vanda Pharmaceuticals Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
First Generation/Standard/Typical Antipsychotics Drug
Second Generation/Atypical Antipsychotics Drug
Third generation Antipsychotics Drug
Other psychotic disorders
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Antipsychotic Drugs Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers